OAR 855-020-0110
Prescribing Practices


A pharmacist located and licensed in Oregon may prescribe and dispense FDA-approved drugs and devices included on either the Formulary or Protocol Compendia, set forth in this Division. A pharmacist shall only prescribe a drug or device consistent with the parameters of the Formulary and Protocol Compendia, and in accordance with federal and state regulations.
(2) A pharmacist must create, approve, and maintain policies and procedures for prescribing post-diagnostic drugs and devices or providing patient care services via implementation of statewide drug therapy management protocols. The policies and procedures shall describe current and referenced clinical guidelines, and include but not be limited to:
(a) Patient inclusion and exclusion criteria;
(b) Explicit medical referral criteria;
(c) Care plan preparation, implementation, and follow-up;
(d) Prescribing drugs and devices pursuant to the formulary and protocol compendia;
(e) Patient education; and
(f) Provider notification.
(3) The pharmacist is responsible for recognizing limits of knowledge and experience and for resolving situations beyond his or her pharmacist expertise by consulting with or referring patients to another health care provider.
(4) For each drug or device the pharmacist prescribes, the pharmacist must:
(a) Assess patient and collect subjective and objective information, including the diagnosis for Formulary Compendia items, about the patient’s health history and clinical status. The pharmacist’s patient assessment shall be performed in a face-to-face, in-person interaction and not through electronic means; and
(b) Utilize information obtained in the assessment to evaluate and develop an individualized patient-centered care plan, pursuant to the statewide drug therapy management protocol and policies and procedures; and
(c) Implement the care plan, to include appropriate treatment goals, monitoring parameters, and follow-up; and
(d) Provide notification, preferably via an interoperable information technology system, to the patient’s identified primary care provider or other care providers when applicable, within five business days following the prescribing of a Compendia drug or device.
(5) The pharmacist shall maintain all records associated with prescribing and other related activities performed for a minimum of 10 years, and a copy must be made available to the patient and provider upon request. Pharmacy records must be retained and made available to the Board for inspection upon request. Records must be stored onsite for at least one year and then may be stored in a secure off-site location if retrievable within three business days. Records and documentation may be written, electronic or a combination of the two.

Source: Rule 855-020-0110 — Prescribing Practices, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=855-020-0110.

Last Updated

Jun. 8, 2021

Rule 855-020-0110’s source at or​.us